Schedule 13G ownership disclosure

Cadrenal Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 127636207

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Havlickova 648 a.s.

    Shares: 78,291.00 · Class: 4.39%

  • Dubnica Property s.r.o.

    Shares: 78,291.00 · Class: 4.39%

  • Miroslav Dornak

    Shares: 78,291.00 · Class: 4.39%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-012684
Form type
SCHEDULE 13G/A
Filer
Cadrenal Therapeutics, Inc.
CIK
CIK 1937993
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub